Brief: MusclePharm Q2 loss per share $0.23
Aug 14 (Reuters) - MusclePharm Corp MSLP.PK
* MusclePharm reports 2017 second quarter financial results
* Q2 loss per share $0.23
* Q2 revenue $26.2 million versus $32.9 million
Source text for Eikon: ID:nPnbmYmVsa
Further company coverage: MSLP.PK
(((Bangalore.newsroom@thomsonreuters.com);))
Recent news on MusclePharm
See all newsBrief: Musclepharm Files Voluntary Petition For Relief Under Chapter 11 Of Title 11
Brief: Musclepharm Applies To List Common Stock On Nasdaq Under Symbol 'MSLP'
Brief: MusclePharm Reports Q3 2021 Financial Results
Brief: Musclepharm Announces Colorado Distribution Partnership With New Age, Inc.
Brief: MusclePharm Q2 loss per share $0.23